AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-1.73%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$53.9M
AUM Growth
+$53.9M
(-8.7%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
American Well
AMWL
$111M
| $27.2M | 50.52% |
6,300,773
| – | – |
|
2
Annexon
ANNX
$226M
| $7.37M | 13.68% |
1,954,978
| – | – |
|
3
Assembly Biosciences
ASMB
$190M
| $4.68M | 8.68% |
2,227,500
| – | – |
|
|
WHWK
4
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $4.62M | 8.57% |
374,785
| – | – |
|
|
RNTX
5
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $4.32M | 8.01% |
16,609,449
| – | – |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.03M | 7.49% |
126,270
| – | – |
|
7
Akebia Therapeutics
AKBA
$833M
| $1.64M | 3.05% |
4,652,561
| – | – |
|